Gilenya
Payments companies reported to CMS as associated with Gilenya. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Gilenya, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Gilenya
These are the largest totals companies reported as associated with Gilenya. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Justin Young | Tracy, MN | Family Medicine | $4,456.98 |
| Harold Rahming | Dyer, IN | Hospitalist | $4,169.57 |
| Brent Porteous | Martinez, CA | Family Medicine | $3,984.05 |
| Joseph Berger | Philadelphia, PA | Neurology (Psychiatry & Neurology) | $3,828.00 |
| Eric Aspinwall | Kansas City, KS | Family Medicine | $3,372.67 |
| David Edwards | Allen, TX | Family Medicine | $3,250.00 |
| Benjamin Greenberg | Dallas, TX | Neurology (Psychiatry & Neurology) | $3,192.00 |
| Peyman Nejatbakhsh Azadani | Los Angeles, CA | Cardiovascular Disease | $3,170.75 |
| Kecia Smette | Glendale, AZ | Family Medicine | $3,064.18 |
| Rebecca Rich | Durham, NC | Internal Medicine | $2,893.89 |
Prescribed Gilenya?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.